Hers is the women’s health brand of Hims & Hers Health, Inc., a company listed on the New York Stock Exchange, and prescriptions issued through it come from clinicians licensed in the patient’s state. So it functions as a real prescriber. What decides whether any individual order was handled well is the paper trail it leaves, and that trail can be read from outside the platform.
Five service lines, five different review paths
The brand covers weight management, hair thinning, skin, mental health, and sexual health. Treating those as one question produces a useless answer, because the clinical stakes and the required screening are not the same across them. A topical retinoid decision made asynchronously is a modest one, and the evidence base for topical retinoids in acne is settled enough that a structured questionnaire captures most of what a prescriber needs. An SSRI decision requires symptom severity and risk screening. A GLP-1 decision requires a contraindication review that includes reproductive status.
Assess the line being bought, not the brand as a whole. The document trail is the tool for that, because it is generated per order.
The documents a working prescription pathway leaves behind
Four artifacts should exist by the time a first shipment arrives. A visit or consultation record naming the reviewing clinician and their credential. A prescription label carrying the prescriber name, the dispensing pharmacy, the drug, the strength, the quantity, and a refill count. Shipping documentation tying the package to that order. And, for an FDA-approved product, a national drug code that resolves to a published label.
Each of those maps onto a public register. A prescriber name goes into a state medical board license lookup, which returns license status, issue date, and public disciplinary history at no cost. The Federation of State Medical Boards runs a search spanning the state registers, and the national provider identifier registry confirms the clinician exists as an enrolled entity. A pharmacy name goes into the relevant state board of pharmacy register. A national drug code goes into DailyMed, where the approved prescribing information for products such as minoxidil, sertraline, or semaglutide sits in full.
The same document checks apply whichever provider signs the prescription, and the weight category alone spans very different operating models. Manufacturer routes such as LillyDirect dispense an approved product directly, broad telehealth platforms such as Ro and Henry Meds run their own intake and pharmacy, and prescriber-gated services such as HealthRX list their GLP-1 medications next to the clinician and pharmacy detail a patient can verify. The register lookups above behave identically across all of them.
The pregnancy question is the sharpest legitimacy signal here
GLP-1 medication is not for use during pregnancy, and the approved labels state that plainly. Review literature on GLP-1 receptor agonists in pregnancy and reproductive health sets out the practical consequences: reproductive status has to be established before treatment starts, contraception is part of the conversation for patients who could conceive, and stopping ahead of a planned pregnancy is a scheduled decision rather than an afterthought. Work on telemedicine in family planning makes a related point, that remote services handle contraceptive care competently when the intake is built for it.
That gives a specific test for a women’s platform. Does the intake ask about pregnancy, plans for pregnancy, breastfeeding, and current contraception, and does it act on the answers. A platform that asks and then declines to prescribe is doing the job. Attempts to read the live intake wording for this article failed because forhers.com returns a 403 response to automated requests, so the questions cannot be quoted here and the check has to be run inside the real flow by someone signing up.
| Artifact | What it should name | Independent check | What it cannot tell you |
|---|---|---|---|
| Consultation record | Reviewing clinician and credential | State medical board license lookup | How long the review took |
| Prescription label | Prescriber, pharmacy, drug, strength, refills | State board of pharmacy register | Whether the dose suits the patient |
| Product identifier | National drug code, or a compounded formula | DailyMed for approved products | Anything, if the item is compounded |
| Facility | 503A pharmacy or 503B outsourcing facility | FDA registered outsourcing facility list | Batch quality of a specific vial |
| Shipment record | Order number, contents, date | Order confirmation held in email | Storage conditions in transit |
Compounded items break part of that trail, by design
A compounded preparation is made to order rather than manufactured under an approved application. It is not FDA-approved, which means the agency has not reviewed it for safety, effectiveness, or manufacturing quality before it reaches a patient. There is no DailyMed entry to open, because there is no approved label. The Drug Supply Chain Security Act tracing rules that follow an approved product through distribution apply differently to compounded items. None of that makes a compounded prescription improper. It does mean two of the five checks above return nothing, and the weight shifts onto the pharmacy license and the facility type instead.
Refills run on two clocks that people confuse
A prescription carries a legal refill authorization, capped by the prescriber and by state law, with an expiry date. A subscription carries a billing cycle set on the day of the first order. They are separate. A card can be charged on the commercial cycle while the clinical authorization is still valid, and a prescription can lapse while the subscription keeps running, which forces a re-evaluation before the next fill. The number printed after the word refills on the label is the one that governs supply.
Comparing that machinery across providers is awkward because each publishes it differently. Competing cash-pay services keep their own accounts of it, and FormBlends hosts a page examining Hers order handling next to its own program. It is a competitor writing about a competitor, so the value is in the checklist it assembles rather than the conclusion it lands on.
What the support channel can and cannot change
Service agents handle billing, addresses, shipping, and account access. A clinical message queue handles anything touching the prescription. A dose change, a switch of molecule, or a request to stop safely belongs in the second queue and will stall in the first. Research on direct-to-consumer telemedicine quality points at the same seam: the model performs when routing between administrative and clinical work is clear.
Frequently asked questions
How do I confirm the clinician who signed my prescription is licensed?
Take the name from the consultation record or the medication label and enter it in the medical board register for the state that governs the visit. The search is free and returns license status, issue date, and public disciplinary history. The national provider identifier registry gives a second confirmation that the person is an enrolled clinician.
Why does my compounded medication have no drug label to look up?
Because compounded preparations are not FDA-approved products and carry no approved prescribing information. The agency has not assessed them for safety, effectiveness, or manufacturing quality. The checkable facts move to the pharmacy instead: its state license, whether it is a 503A pharmacy or a registered 503B outsourcing facility, and what the dispensing paperwork states.
Can I be prescribed a weight medication if I am trying to conceive?
GLP-1 medication is not indicated in pregnancy, and the published reviews on reproductive health describe stopping before a planned conception as a timed clinical decision. A prescriber who screens for pregnancy, contraception, and conception plans and then declines is applying the label correctly rather than obstructing an order.
Does a refill arriving automatically mean nobody reviewed it?
Not by itself. A valid prescription with refills remaining permits scheduled dispensing without a fresh visit, which is ordinary pharmacy practice. What matters is whether the authorization is still live and when it expires. Both appear on the label, and a lapsed authorization should interrupt shipments rather than pass unnoticed.
Is asynchronous review legal for these medications?
Store-and-forward review is permitted in many states for many conditions, subject to each state’s telemedicine rules and to federal restrictions on controlled substances. The permitted scope varies by state and by drug class. The reviewing clinician still has to hold a license in the patient’s state, which is the part a patient can verify directly.
